Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 FDA Grants Abbott, Boston Scientific Approval for Narrow Stent - Medical Product Outsourcing

What are you searching for?

Sign in

FDA Grants Abbott, Boston Scientific Approval for Narrow Stent

New narrow stents approved for manufacturing leaders.

By: Laura Sassano

The U.S. Food and Drug Administration has granted approval to Abbott Laboratories and Boston Scientific Corp. for narrow heart stents to help patients with narrow blood vessels. The companies are the leading sellers of drug-coated stents.

The stents are approved for use in vessels as small as 2.25 millimeters in diameter.

Both companies claim that approximately 10 percent of patients who need artery-clearing angioplasty have vessels smaller than 2.5 millimeters.
Abbott will manufacture the stent, which they will market as Xience Nano and Boston Scientific will market as Promus. An agreement that runs through June 2012 guarantees Abbott 40 percent of Boston Scientific’s profits.

Last year, Abbott Park, Ill.-based Abbott Laboratories generated $1.34 billion in revenue from drug-coated stents. They were bested only by Natick, Mass.-based Boston Scientific’s $1.54 billion.

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Add Medical Product Outsourcing as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters